1. Targeting stem cells in the realm of drug-resistant breast cancer;Dey;Breast Cancer (London),2019
2. HER3 signaling and targeted therapy in cancer;Mishra;Oncol. Rev.,2018
3. Activating HER2 mutations in HER2 gene amplification negative breast cancer;Bose;Cancer Discov.,2013
4. Structures of the HER2–HER3–NRG1β complex reveal a dynamic dimer interface;Diwanji;Nature,2021
5. Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C-y or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB / EGFR family members;Fedi,1994